Trial NCT02793583

View at ClinicalTrials.gov 
Org. Study IDs: UTX-TGR-205

Last trial update was posted on 2022-07-21

MeSH Interventions

Bendamustine Hydrochloride

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin

Other Conditions

Diffuse Large B-Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma

Stopping Reasons

Strategic/Business Decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID